![Andrew Kucharchuk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Kucharchuk
Financieel Directeur/CFO bij
CHAIN BRIDGE I
Vermogen: 510 000 $ op 30-09-2026
Profiel
Andrew Albert Kucharchuk bekleedt de functie van Voorzitter & Chief Executive Officer bij Adhera Therapeutics, Inc. Hij zit ook in de raad van bestuur van Theralink Technologies, Inc. (Colorado), OncBioMune, Inc. en Theralink Technologies, Inc. (voormalig Chief Financial Officer & Director) en lid van de Kappa Alpha Order. De heer Kucharchuk behaalde een bachelordiploma aan de Louisiana State University en een MBA aan de A.B. Freeman School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,33% | 03-10-2025 | 25.000 ( 0,33% ) | 261 875 $ | 30-09-2026 |
0,3% | 29-04-2026 | 25.000 ( 0,3% ) | 248 125 $ | 30-09-2026 |
-.--% | 28-04-2026 | 0 ( -.--% ) | - $ | 30-09-2026 |
Actieve functies van Andrew Kucharchuk
| Bedrijven | Functie | Begin |
|---|---|---|
| CHAIN BRIDGE I | Financieel Directeur/CFO | 01-04-2024 |
| WINDTREE THERAPEUTICS, INC. | Directeur/Bestuurslid | 03-08-2025 |
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Financieel Directeur/CFO | - |
Kappa Alpha Order | Corporate Officer/Principal | - |
Eerdere bekende functies van Andrew Kucharchuk
| Bedrijven | Functie | Einde |
|---|---|---|
Two Hands Corp.
 Two Hands Corp. Internet RetailRetail Trade Operates online delivery marketplace and operates grocery stores and provides food distribution services | Financieel Directeur/CFO | 20-02-2025 |
| ADHERA THERAPEUTICS, INC. | Algemeen Directeur | 30-09-2022 |
| THERALINK TECHNOLOGIES, INC. | Algemeen Directeur | 05-06-2020 |
OncBioMune, Inc.
 OncBioMune, Inc. BiotechnologyHealth Technology Develops biotechnologies for cancer treatment | Algemeen Directeur | 01-09-2023 |
Opleiding van Andrew Kucharchuk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
Two Hands Corp.
Two Hands Corp. Internet RetailRetail Trade Operates online delivery marketplace and operates grocery stores and provides food distribution services | Retail Trade |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kappa Alpha Order | |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
A.B. Freeman School of Business
 A.B. Freeman School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Engages in the research of human genome sequencing and provides screening test for detection of cancer | Health Technology |
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology Develops biotechnologies for cancer treatment | Health Technology |
Theralink Technologies, Inc.
 Theralink Technologies, Inc. BiotechnologyHealth Technology Operates as a precision medicine company | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Health Technology |
Chain Bridge I
 Chain Bridge I Financial ConglomeratesFinance Operates as a blank check company | Finance |
